ResMed (RMD) | Stock Overview & Key Data
ResMed Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $301.34 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ResMed
RMD
|
32.03B Large-cap | -0.21% | -4.53% | -16.42% | -23.84% | -21.27% | -21.88% | -11.08% | -17.97% | 233.76% | 527.92% | 775.81% |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -0.49% | -1.09% | -13.84% | -25.55% | -25.88% | -19.74% | 24.81% | 40.32% | 476.52% | 974.11% | 3,431.44% |
| 56.10B Large-cap | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% | |
|
Alcon
ALC
|
45.84B Large-cap | 0.27% | 4.16% | -14.78% | -16.29% | -14.57% | -22.45% | -17.74% | -4.83% | 22.82% | 22.82% | 22.82% |
| 22.07B Large-cap | 3.65% | 9.42% | 37.92% | 21.91% | 19.91% | 48.18% | -9.18% | -6.66% | 345.01% | 1,441.58% | 1,794.12% | |
|
Hologic
HOLX
|
16.97B Large-cap | 0.56% | 0.56% | 1.40% | 12.23% | 1.94% | 31.39% | -9.66% | -0.85% | 110.15% | 246.29% | 206.74% |
Ownership & Short Interest
Calculate Your ResMed Investment Returns
Long-Term Investment Performance Analysis
ResMed stock price in Jul 2016 was $65.93, A $1,000.00 lump sum investment in ResMed made 9 years ago would be worth approximately $2,923.40 today, representing a strong return of 192.34%. This translates to an annualized return (CAGR) of 11.43%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is RMD's 52-week high and low?
- In the last 52 weeks, ResMed reached a high of $293.81 (on August 22, 2025) and a low of $180.27 (on N/A).
- What is the market cap and P/E ratio for RMD?
- Curious about ResMed's size and valuation? Its market capitalization stands at 32.03B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.69, and the forward P/E (looking ahead) is 18.02.
- Does RMD pay dividends? If so, what's the yield?
- Yes, ResMed is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.92%, and the company has paid an average of $2.09 per share annually over the past 3 years.
- Who are ResMed's main competitors or similar companies to consider before investing?
When looking at ResMed, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -19.74% 24.81% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.01% -28.08% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -22.45% -17.74% West Pharmaceutical
WST22.07B Healthcare Medical Instruments & Supplies 48.18% -9.18% Hologic
HOLX16.97B Healthcare Medical Instruments & Supplies 31.39% -9.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for ResMed Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of ResMed's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 25.68%, the Debt to Equity ratio from the most recent quarter is 13.41, and its Gross Profit Margin stands at 61.76%.
- What is the recent revenue and earnings growth for RMD?
- Looking at ResMed's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.00%, and quarterly earnings saw a YoY growth of 13.90%.
- How much of RMD stock is held by insiders and institutions?
- Wondering who owns ResMed stock? Company insiders (like executives and directors) hold about 0.50% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 68.82%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.